Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well linsitinib works in treating younger and adult patients
with gastrointestinal stromal tumors. Linsitinib may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth.